About the project
Our lab is developing a platform to correct patient-specific mutations in T-cells and blood stem cells, with the ultimate goal of reinfusing these gene-corrected cells as a form of autotransplant therapy. This work places you at the intersection of translational immunology, gene therapy, and regenerative medicine.
What you'll do
Depending on your interests and background, your project may include:
-
Demonstrating correction of genetic mutations in immune cells
-
Participating in animal experiments
-
Characterizing edited cells with different techniques (e.g., droplet digital PCR, flow cytometry)
-
Optimizing cell culture systems to support growth of immune-deficient cells
You will be supervised by a senior scientist or an experienced PhD student in a dynamic, international research environment.
Start Dates
We accept two Master’s students per year, with start times between June and August.
Why Join Us?
-
Hands-on experience with CRISPR gene editing and cell therapy
-
Exposure to a broad range of immunodeficiencies and molecular techniques
-
Excellent track record: our Master’s alumni have quickly secured positions in both academia and industry
How to Apply
If you’re interested, please contact:
-
Emma Haapaniemi (Group Leader) emma.haapaniemi@ncmbm.uio.no
Send your CV and a short motivation letter outlining your interests and preferred start date.